Comparative Effects of Hypopressive Exercises and Paula Method in Postpartum Women.
This study will be a randomized clinical trial with a sample size of 60 postpartum females. The setting of the study will be Bilal Medicare, Sargodha. 60 postpartum women will be included based on age, parity, mode of delivery and type of urinary incontinence. Women with primary gravida, cesarean section and urge and m
| Condition(s) | Urinary Incontinence (UI) |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | This study will be a randomized clinical trial with a sample size of 60 postpartum females. The setting of the study will be Bilal Medicare, Sargodha. 60 postpartum women will be included based on age, parity, mode of delivery and type of urinary incontinence. Women with primary gravida, cesarean section and urge and mixed urinary incontinence will be excluded. This study aims to compare the effectiveness of Hypopressive Exercises and the Paula Method in improving urinary incontinence severity, pelvic floor muscle strength and quality of life in postpartum women. Patients of both groups receive two treatment sessions per week over an 8-week period. Group A will be given Hypopressive exercise and Group B will be given Paula exercise protocol. Both groups will perform a standardized kegel ex |
| Who can participate | Inclusion Criteria: * • Multipara women from 25-40 years * Six weeks postpartum * Vaginal delivery method * Reported ≥1 episodes of urine leakage per week * Diagnosed with SUI (ICIQ-UI SF ≥6) Exclusion Criteria: * • No pelvic floor physiotherapy in last 6 months * Patients with any medical and gynaecological risk factors and /or conditions * Patients with any neurological problems, urinary tract infection, diabetes mellitus, hepatitis and ascites * Pelvic surgery in last 6 months * Mental or cognitive impairment |
| Ages | 25 Years to 40 Years |
| Sex | Female |
| Lead sponsor | Riphah International University |
| Locations | Sargodha, Punjab Province, Pakistan |
| Start date | 2025-10-01 |
| NCT ID | NCT07628322 |
| Official listing | https://clinicaltrials.gov/study/NCT07628322 |